The Cigna Group (ci)
CI — Company Overview
The Cigna Group (CI) is a large-cap company in the Healthcare sector, operating in Healthcare Plans.
| Ticker | CI |
| Sector | Healthcare |
| Industry | Healthcare Plans |
| Exchange | NYQ |
| Market cap | $72.73B |
| Last price | $275.25 |
| Size category | Large Cap |
CI — Business Description
The Cigna Group (CI) operates in Healthcare Plans within the broader Healthcare market. The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and Intern…
Official website: https://www.thecignagroup.com.
CI — Investment Thesis
The investment thesis for The Cigna Group (CI) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.
- Revenue is expanding at roughly 6.7% year-over-year (public data).
- Trailing P/E near 11.18× suggests a value-oriented earnings multiple.
- Forward P/E (8.22×) is below trailing P/E — earnings may be expected to improve.
- Dividend yield near 2.3% adds an income component to total return.
- Equity market capitalization is approximately $72.73B.
Analyst consensus, price targets & estimates is available in Vest Terminal for Professional and Enterprise subscribers.
CI — Financial Health
Financial health for The Cigna Group (CI) is summarized from publicly reported profitability, leverage, and cash-flow metrics.
Profit margin near 2.3% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $7.98B supports balance-sheet flexibility.
| Trailing P/E | 11.18× |
| Forward P/E | 8.22× |
| Price / Sales | 0.26× |
| Price / Book | 1.73× |
| Gross margin | 9.1% |
| Operating margin | 4.0% |
| Profit margin | 2.3% |
| Return on equity | 16.8% |
| Debt / Equity | 74.29 |
| Free cash flow | $7.98B |
CI — Growth Outlook
Growth outlook for The Cigna Group (CI) depends on demand trends in Healthcare Plans and the company's ability to convert revenue into sustainable earnings.
- Revenue growth of 6.7% suggests steady but measured expansion.
- Earnings growth of 10.2% year-over-year supports improving profitability.
- Price is 12.7% below the 52-week high.
- Shares trade 14.9% above the 52-week low — limited rebound so far.
CI — Competitive Position
The Cigna Group (CI) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.
- Competes within Healthcare, specifically in Healthcare Plans.
- Market capitalization of $72.73B places CI among large-cap peers.
- Gross margin of 9.1% should be benchmarked against direct competitors.
CI — Strengths
Strengths for The Cigna Group (CI) inferred from public financial metrics:
- Revenue growth of 6.7% year-over-year.
- Earnings growth of 10.2% year-over-year.
- Return on equity near 16.8% — efficient use of shareholder capital.
- Positive free cash flow ($7.98B).
- Dividend yield of 2.3% for income-oriented holders.
- Moderate leverage (debt/equity 74.29).
CI — Weaknesses
Weaknesses and pressure points for The Cigna Group (CI) based on available data:
- Thin profit margin (2.3%).
CI — Opportunities
- Trading 14.9% above the 52-week low — potential recovery if fundamentals stabilize.
- Dividend yield of 2.3% appeals to total-return investors.
- Positive free cash flow enables reinvestment, debt reduction, or shareholder returns.
- Forward earnings multiple below trailing P/E — potential earnings acceleration ahead.
CI — Risks
- Thin margins leave less room for operational missteps.
CI — Summary
The Cigna Group (CI) is a large-cap Healthcare company focused on Healthcare Plans, listed on NYQ. Last price $275.25 with market cap $72.73B. Trailing P/E 11.18×. Revenue grew 6.7% year-over-year per public data. Notable strengths include revenue growth of 6.7% year-over-year. Key watch items include thin profit margin (2.3%). Detailed estimates, ownership, and news for The Cigna Group remain locked in Vest Terminal for subscribers.
The Cigna Group FAQ
What does The Cigna Group (CI) do?
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services…
What is CI's P/E ratio?
The Cigna Group has a trailing P/E of 11.18× based on publicly available market data.
Does CI pay a dividend?
Indicated dividend yield: 2.3%. Confirm ex-dates and payout history in Vest Terminal.
What sector is CI in?
The Cigna Group is classified in Healthcare (Healthcare Plans) on NYQ.
What is CI's market capitalization?
Approximate market cap: $72.73B.
What are the main risks for CI?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of CI?
Potential positives include revenue growth of 6.7% year-over-year, earnings growth of 10.2% year-over-year.
Where can I get analyst estimates for CI?
Consensus estimates, price targets, and detailed analyst data for The Cigna Group are available to Professional subscribers in Vest Terminal — not on this public summary page.